Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework.

MLA

Saloner, Brendan, et al. “Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework.” Medical Care, vol. 61, no. 2, Feb. 2023, pp. 95–101. EBSCOhost, https://doi.org/10.1097/MLR.0000000000001802.

APA

Saloner, B., Chang, H.-Y., Alexander, G. C., & Stein, B. D. (2023). Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework. Medical Care, 61(2), 95–101. https://doi.org/10.1097/MLR.0000000000001802

Chicago

Saloner, Brendan, Hsien-Yen Chang, G Caleb Alexander, and Bradley D Stein. 2023. “Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework.” Medical Care 61 (2): 95–101. doi:10.1097/MLR.0000000000001802.